For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Sabadell 8208

0 studies enrolling now · 10 studies all time

What they study most

Colorectal Cancer, Diabetes Mellitus, Type 2, Postmenopausal Osteoporosis, Psoriasis, Arthritic, Psoriatic Arthritis, Rheumatoid Arthritis, Sepsis, Severe Sepsis, Spondyloarthritis

Studies at this site

• A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis — Completed
• A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis — Completed
• A Study in Second Line Metastatic Colorectal Cancer — Completed
• VERtebral Fracture Treatment Comparisons in Osteoporotic Women — Completed
• A Study in Moderate to Severe Rheumatoid Arthritis — Completed
• A Study of Ixekizumab in Participants With Active Psoriatic Arthritis — Completed
• A Study in Participants With Type 2 Diabetes Mellitus — Completed
• Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes — Completed
• Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock — Completed
• Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated) — Completed